In mice treated with αNKG2A-N215, tumor-infiltrated CD8+ T and NK cells were 12.6 folds and 2.7 folds those of peripheral immune effector cells (Figure 5(D)), respectively, indicating that αNKG2A-N215 predominantly induced intratumoral antitumor immune responses. This evidence concerns the gene CD8A and neoplasm.